New Study Finds 85% of Aneurysms Identified by Viz™ ANEURYSM had not Been...
Median size of aneurysms was 5mm, suggesting that AI-powered detection of incidental cerebral aneurysms can improve patient care pathways. SAN...
Nov 10, 2022
All Resources
Explore our latest resources
Viz.ai Launches AI-Powered Viz™ Cardio Suite
Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals CHICAGO & SAN FRANCISCO--(BUSINESS WIRE)--AMERICAN HEART...
Nov 04, 2022
Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™...
Partnership delivers critical insights to cardiac care teams for faster patient triage and care. SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in...
Nov 02, 2022
AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System...
AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients...
Oct 31, 2022
Viz.ai Names Jieun Choe Chief Marketing Officer
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief...
Oct 25, 2022
Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm
Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity. SAN FRANCISCO – September...
Sep 01, 2022
Making Moves at Vascular Events this Summer
The Viz.ai team has been busy this summer attending several vascular events, meeting with clinical leaders advancing the vascular surgery...
Aug 24, 2022
Viz.ai Receives FDA 510(k) Clearance for Viz™ SUBDURAL (SDH)
AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care SAN FRANCISCO - July 27, 2022...
Jul 27, 2022